The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis.
D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D002991:Clofazimine / Q000494:pharmacology; D004579:Electron Transport; D007893:Leishmania donovani / Q000187:drug effects*; D007894:Leishmania mexicana / Q000187:drug effects*; D007896:Leishmaniasis / Q000188:drug therapy; D007898:Leishmaniasis, Visceral / Q000188:drug therapy; D008751:Methylene Blue / Q000494:pharmacology; D008773:Methylphenazonium Methosulfate / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D009285:Naphthoquinones / Q000494:pharmacology* / Q000627:therapeutic use; D009547:Nifurtimox / Q000494:pharmacology; D014812:Vitamin K / Q000494:pharmacology
D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D014812:Vitamin K; D008773:Methylphenazonium Methosulfate; D002991:Clofazimine; D009547:Nifurtimox; D008751:Methylene Blue; D002746:Chlorpromazine; C014758:plumbagin